Product Details

Oseltamivir Tablets BP 30 mg deliver a high-quality antiviral therapy that meets British Pharmacopoeia (BP) standards. This formulation manages influenza A and B infections by effectively blocking viral spread within the body.

Each tablet contains:

• Oseltamivir, a neuraminidase inhibitor antiviral that blocks the release and spread of influenza virus particles by inhibiting the neuraminidase enzyme on the virus surface.

Doctors commonly prescribe Oseltamivir for the treatment of acute uncomplicated influenza in patients within the early symptomatic window, as well as for influenza post-exposure prophylaxis. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable therapeutic results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP-standard compliant antiviral therapy
• Treats influenza A and B infections
• Delivers effective neuraminidase-inhibiting antiviral action
• Accurate 30 mg dosage per tablet
• Maintains a high-purity, stable formulation
• Uses hygienic blister packaging for safe storage
• Suits hospital, clinical, and pharmacy use